9,10-dimethyl-1,2-benzanthracene has been researched along with Cancer of Oropharnyx in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Amornphimoltham, P; Califano, JA; Callejas-Valera, JL; Gutkind, JS; Iglesias-Bartolome, R; Martin, D; Molinolo, AA; Palacios-Garcia, J | 1 |
Chen, YK; Lin, CC; Lin, LM | 1 |
2 other study(ies) available for 9,10-dimethyl-1,2-benzanthracene and Cancer of Oropharnyx
Article | Year |
---|---|
mTOR inhibition prevents rapid-onset of carcinogen-induced malignancies in a novel inducible HPV-16 E6/E7 mouse model.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Carcinogens; Carcinoma, Squamous Cell; Cell Proliferation; Gene Expression Regulation, Neoplastic; Human papillomavirus 16; Humans; Mice; Oncogene Proteins, Viral; Oropharyngeal Neoplasms; Papillomavirus E7 Proteins; Papillomavirus Infections; Phorbol Esters; Repressor Proteins; Sirolimus; TOR Serine-Threonine Kinases | 2016 |
Placental glutathione S-transferase isoenzyme expression during promotion of two-stage hamster cheek-pouch carcinogenesis.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Cheek; Cricetinae; Glutathione Transferase; Hyperplasia; Immunohistochemistry; Isoenzymes; Male; Mouth Mucosa; Neoplastic Processes; Oropharyngeal Neoplasms; Tetradecanoylphorbol Acetate; Time Factors | 1999 |